@article{f69b5e46399244f79335714006ad296c,
title = "RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection",
abstract = "Not applicable",
keywords = "Angiotensin-Converting Enzyme Inhibitors, Anti-Inflammatory Agents, Non-Steroidal, Anticoagulants, COVID-19, Humans, Hypoglycemic Agents, Renin-Angiotensin System, SARS-CoV-2, Angiotensin-Converting Enzyme Inhibitors, Anti-Inflammatory Agents, Non-Steroidal, Anticoagulants, COVID-19, Humans, Hypoglycemic Agents, Renin-Angiotensin System, SARS-CoV-2",
author = "Elisa Gremese and Stefano Alivernini and Gianfranco Ferraccioli",
year = "2021",
doi = "10.1073/pnas.2025609118",
language = "English",
volume = "118",
pages = "N/A--N/A",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences:2101 Constitution Avenue Northwest:Washington, DC 20418:(877)314-2253, (615)377-3322, EMAIL:
[email protected], INTERNET: http://www.pnas.org, Fax: (615)377-0525",
}